Treatment of IU(DME)(NC[(t)Bu]Mes)(3) (2-I-DME) with 4 equiv of KC(8) and 0.5 equiv of naphthalene in DME allowed the isolation of a naphthalene-bridged compound, K(2)(mu-eta(6),eta(6)-C(10)H(8))[U(NC[(t)Bu]Mes)(3)](2) (K(2)-2(2)-mu-C(10)H(8)), in 60% yield as a dark brown powder. The twelve U-C distances are rather short, varying from 2.565(11) to 2.749(10) A. Treatment of M(2)-2(2)-mu-C(10)H(8) (M = Na, K) with 2 equiv of 1,3,5,7-cyclooctatetraene afforded a mixture of two products: M-2-COT and 2(2)-mu-COT. Compound 2(2)-mu-COT can be assembled independently in 90% yield by salt elimination upon reaction of M-2-COT with iodide 2-I-DME. The U-C(arene) distance in compound 2(2)-mu-COT is longer than that in its naphthalene counterpart K(2)-2(2)-mu-C(10)H(8)(2.822 vs 2.634 A), in accord with bonding considerations. A DFT study performed on model compounds for both M(2)-2(2)-mu-C(10)H(8) and 2(2)-mu-COT indicates that the delta bonds present in the former compound show better covalent overlap.
No takes yet. Share an insight, caveat, or question.
Diaconescu et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: